Protein Microarray Market Growth Analysis: Opportunities, Challenges & Forecasts According to a newly published market research report by 24LifeSciences, global protein microarray market is valued at USD 951.5 million in 2026 and is projected to reach USD 1.65 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period. A protein microarray, often termed a protein chip, is a high-throughput analytical platform designed to track the interactions, activities, and functions of thousands of proteins simultaneously. This powerful technology involves immobilizing an array of capture proteins such as antibodies, antigens, or peptides onto a solid support surface like a glass slide, nitrocellulose membrane, or microtitre plate. Its established efficacy in proteomic analysis continues to underpin its importance in biomarker discovery, drug development, and clinical diagnostics, transforming how researchers study complex biological systems. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9116/protein-microarray-market

Peptide and Heparin Market Size to Reach USD 58.9 Billion by 2031 | Growth Insights Global peptide and heparin market is undergoing steady and strategic expansion, supported by rising demand for advanced biologic therapies and critical anticoagulation treatments. Valued at USD 42.5 billion in 2024, the market is projected to reach USD 58.9 billion by 2031, growing at a CAGR of 4.8% during the forecast period. This growth reflects the increasing clinical reliance on peptide-based drugs and heparin across cardiovascular care, oncology, and metabolic disorder management worldwide. Access the complete report https://www.24lifesciences.com/peptide-and-heparin-market-9010